Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The effect of YM-254890 on the P2Y1 and P2Y12 signal transduction pathways using C6-15 cells stably expressing the human P2Y1 or P2Y12 receptors is examined
(2011) Cancer Research
When applied to live cells
1-difluoroethyl)-12-(methoxycarbonyl)-1
Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro
Eprosartan mesylate Size:Solid 10 mg The effect of YM-254890 onEprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvier. Eprosartan is sometimes paired with hydrochlorothiazide, whereupon it is marketed in the US as Teveten HCT and elsewhere as Teveten Plus. The drug acts on the renin angiotensin system to decrease total peripheral resistance in two ways. First, it blocks the binding of angiotensin II to AT1